# How Should Insurers Build AI Risk Controls in 2026?

Amelia Palmer · September 25, 2026

> Direct answer: what effective insurer AI risk controls look like Effective insurer AI risk controls are a governance system for deciding where...

## Direct answer: what effective insurer AI risk controls look like

Effective insurer AI risk controls are a governance system for deciding where artificial intelligence may be used, how its outputs will be tested and challenged, who remains accountable, and what happens when the system fails. They should cover models already operating inside underwriting, claims, fraud detection, customer service, investment management, and pricing, as well as AI-enabled tools supplied by external vendors. As of 26 September 2026, controls should also address newer operational risks from autonomous or agentic systems, including erroneous decisions, cyberattacks, biased outcomes, manipulated data, inaccessible model decisions, and reliance on software whose behavior cannot be fully observed.

**Also worth reading:** [What Proof Do Insurers Want for Responsible AI Controls, and How Do You Get It in 2026?](https://in-surely.com/knowledge/what_proof_do_insurers_want_for_responsible_ai_controls_and_how_do_you_get_it_in_2026.php) · [How Should Insurers Control AI Underwriting Risk Without Slowing Decisions?](https://in-surely.com/knowledge/how_should_insurers_control_ai_underwriting_risk_without_slowing_decisions.php) · [What Are the Best AI Agent Risk Controls for Businesses in 2026?](https://in-surely.com/knowledge/what_are_the_best_ai_agent_risk_controls_for_businesses_in_2026.php)

A defensible program combines inventory, risk classification, data governance, independent validation, human approval, monitoring, incident reporting, and regulatory records. The required intensity should depend on the decision and its potential impact: an AI tool that drafts a customer email does not warrant the same control structure as a model influencing reserve amounts, claim denials, or capacity decisions. A useful starting threshold is to classify every AI use by whether it merely assists an employee, recommends a decision, or directly triggers an action, then apply stronger testing and approval gates to the latter two categories.

The objective is not to prohibit AI or demand perfect models. Insurers routinely operate with imperfect models because models can process information more quickly and consistently than manual teams, especially when claims data is sparse or changing. The objective is to prevent an unmeasured weakness from becoming a solvency, conduct, reputational, or legal event. Regulators and rating agencies are paying increasing attention to AI governance, and surveys reported as of 2026 indicate that governance maturity, data readiness, and operating controls will differentiate insurers. An AI Insurance Broker can help carriers compare providers, coverage, exclusions, and control requirements, but it cannot replace governance owned by the insurer or its board.

## Why insurers need controls rather than a generic AI policy

AI creates familiar risks in unfamiliar forms. An insurer already manages credit, market, underwriting, reserve, catastrophe, and operational risks; AI can alter the speed, scale, opacity, and interdependence of those exposures. A faulty model can repeat an error across thousands of files, while a compromised vendor account can introduce malicious outputs into several connected workflows. If employees cannot explain why a recommendation was produced, regulators may also question whether the decision was consistent, lawful, or adequately supervised.

The control rationale is especially strong when AI is used without representative claims history. Frontier technology companies and emerging AI-agent businesses can present hazards not adequately represented in historical loss data. In those cases, insurers may need to combine quantitative evidence with expert judgment, scenario testing, contractual requirements, and specialist underwriting rather than infer risk solely from an ordinary industry benchmark. A model trained on conventional software or cyber incidents may not recognize an AI agent taking unauthorized actions, propagating manipulated content, or causing losses through an API.

AI governance also responds to evidence that adoption is occurring faster than oversight. Reporting cited in the research context says that fewer than 1 in 10 insurers using AI for claims had an AI oversight body, suggesting a possible accountability gap. That figure should not be applied to every insurer because definitions and samples may differ, but it illustrates why a written governance forum matters. The board or designated risk committee should receive defined information about approved uses, model performance, exceptions, incidents, vendor dependencies, and unresolved regulatory issues.

Controls should be proportionate, not theatrical. A large carrier may establish a central model-risk function while business units retain ownership of their systems. A smaller insurer may assign responsibility to its chief risk officer, compliance lead, and an external validator. The form can vary, but three questions should always have clear answers: who approved the system, what evidence supports its continued use, and who has authority to suspend it?

## The operating framework for model and agent governance

The first stage is inventory. Insurers should maintain a register of AI and machine-learning systems, including predictive models, generative tools, rules that imitate learned behavior, autonomous agents, and embedded vendor products. Each record should identify the business owner, developer, data sources, intended use, prohibited uses, affected customers, decision authority, third parties, deployment location, and the version in production. Software used only for internal search or coding should not be ignored, although it may receive a lighter review than a system affecting claims or policy terms.

The second stage is classification. A three-tier model is workable: assistive systems with limited ability to influence outcomes; advisory systems that materially shape recommendations; and autonomous systems that initiate or execute actions. Controls can then escalate by tier. For example, a low-impact drafting tool might receive privacy screening and ordinary security testing, while a claims agent with authority to open, evaluate, or close cases might require independent testing, transaction limits, escalation rules, immutable logs, and tested rollback procedures.

The third stage is evidence. Validation should use representative and time-separated data, stress scenarios, error analysis, fairness testing where appropriate, security testing, and comparison with existing processes. Performance thresholds should be set before deployment. A cyber model may be evaluated using false-negative and false-positive rates, while a claims triage system may be measured by processing time, override rates, complaint rates, reserve accuracy, or customer outcomes. A threshold such as fewer than 5% of decisions requiring manual override is not inherently good; excessive overrides can mean the system is not useful, while very few overrides can mean inadequate review.

Finally, insurers need continuous monitoring. Changes in data, model versions, regulations, business strategy, and connected systems can invalidate an earlier approval. High-risk models should be revalidated at least annually and after material changes, with more frequent monitoring of drift and operational performance. As a practical governance rule, any change affecting eligibility, pricing, claims handling, fraud decisions, reserves, or payments should trigger an impact review before release.

## Data, third-party, and cybersecurity controls insurers cannot skip

AI risk is often inherited through data and vendors. An insurer may not control the training data, cloud environment, model weights, prompts, retrieval sources, or interfaces used by a third-party platform. Procurement should therefore require documentation of intended uses, data locations, retention periods, subcontractors, security controls, incident-notification periods, audit rights, model-change procedures, and responsibilities after termination. A vendor promising that its service is “secure” is not enough; the insurer needs terms that connect service performance to its own obligations.

Contracts should address intellectual property, confidentiality, privacy, professional error, cyber events, service interruption, and regulatory cooperation. They should state whether customer data may be used to train shared or generalized models and whether the vendor must support deletion, portability, or exit. For higher-risk uses, insurers should require a right to obtain validation reports, participate in incident exercises, and receive advance notice of material model changes. They should also define whether remediation is included in fees or charged as additional work.

Agentic AI requires stricter interface controls. A claims or underwriting agent should operate with least-privilege access, short-lived credentials where feasible, approved tools, restricted data, and spending or transaction limits. It should not be permitted to execute arbitrary code, change system configuration, or send external communications without an appropriate approval rule. A machine identity used by the agent should be inventoried, monitored, and revoked promptly when no longer required.

Detection should cover both malicious and non-malicious failure. Security teams need alerts for abnormal data access, prompt injection, poisoned documents, unusual tool calls, mass exports, privilege changes, and deviations from normal operating patterns. Insurers should also preserve enough evidence to reconstruct a decision: input reference, model or configuration version, retrieved material, tool calls, output, human review, and final action. This record should be produced without retaining unnecessary personal data.

## Human oversight, customer fairness, and explainable decision rights

Human involvement should be meaningful rather than ceremonial. A reviewer needs authority, training, sufficient time, access to the underlying evidence, and enough expertise to challenge the system. A policy that requires an employee to click “approve” on thousands of low-confidence outputs may provide little protection. High-impact decisions should be routed to qualified personnel when confidence is low, the applicant is affected by a protected characteristic, the amount exceeds a defined threshold, or the output conflicts with known facts.

Customer-facing outcomes require fairness controls. Although automated underwriting and claims practices can be lawful, insurers should test whether variables, proxies, data gaps, or model design produce materially different outcomes across relevant groups. The correct test depends on the jurisdiction and use; universal thresholds should not be imposed without legal and actuarial analysis. Insurers should document the business purpose of features, assess data quality, provide an accessible route for correction or appeal, and examine complaints alongside technical accuracy.

Explainability should be matched to the audience. A customer may need a clear reason for a claim decision, a producer may need the major factors affecting price, and a regulator may need validation evidence and decision records. Full disclosure of model weights or an unexplained probability score is not automatically the most useful or safest approach. Regulators may instead expect documented governance, appropriate validation, and the ability to reproduce a decision internally.

Insurers should also define when automation must stop. Appropriate triggers include sustained performance deterioration, unexpected override rates, cyber incidents, incomplete data rights, regulatory confusion, or an inability to distinguish the system version involved in a complaint. An emergency shutdown should preserve evidence, transfer work to a controlled manual process, and activate a documented recovery plan. A rollback tested only on paper is not an effective control.

## Comparison: internal controls, vendor assurance, and independent validation

| Feature | Internal control program | Vendor assurance | Independent validation or specialist review |
| --- | --- | --- | --- |
| Primary purpose | Establishes ownership, approval, monitoring, and escalation for every AI use | Confirms the supplier’s security, development, and support practices | Tests performance, assumptions, limits, or a specific high-risk use |
| Best fit | Portfolio-wide governance | Routine outsourced platforms and services | Material underwriting, claims, pricing, reserves, or agentic decisions |
| Main limitation | Cannot cover supplier internals or every technical detail | Assurance may not match the insurer’s actual deployment or configuration | Adds cost and time and may become outdated after model changes |
| Evidence needed | Register, approvals, thresholds, logs, training, incidents | Contract, audit report, certifications, incident terms, change notices | Test design, sample results, stress tests, findings, remediation |
| Accountability | Business owner and insurer management remain responsible | Vendor manages its platform, but the insurer manages third-party risk | Reviewer advises or validates; management still approves risk acceptance |
| Expected review cycle | Continuous monitoring and risk-based reviews | At onboarding, material change, incident, and periodic renewal | Before launch, annually for high-risk systems, and after material change |

These approaches are not substitutes. Vendor assurance reduces the work needed to understand a supplier but does not prove that a particular insurer configuration produces suitable results. Independent validation is useful for consequential decisions but is wasteful if applied identically to every internal email assistant. The efficient model is layered: a lightweight inventory process for all tools, contractual assurance for third parties, and deeper validation where financial, customer, or operational exposure warrants it.
Cost should also be considered. Initial work commonly depends less on the cost of the AI tool than on the affected system and available data. A low-risk internal application may require modest legal, privacy, security, and risk review effort, while a production claims model or autonomous agent can require months of data work, scenario design, legal analysis, and independent testing. Specialized actuarial, cybersecurity, legal, fairness, or model-risk expertise may be purchased separately. Cost should not be the sole selection criterion: a more expensive insurer with transparent controls, credible validation, and usable audit evidence may be preferable to a cheaper quote whose exclusions leave the policyholder exposed.

## Practical steps and a 12-month implementation timetable

During the first 90 days, an insurer should identify material uses of AI, including tools purchased outside the formal technology process. Management should appoint an accountable executive, establish cross-functional governance, and agree definitions for acceptable use, restricted use, and prohibited use. Existing policies should be mapped against actual practice, with particular attention to outsourcing, data protection, cybersecurity, customer treatment, records, and business continuity. High-risk deployments should be paused where no accountable owner or reliable fallback exists.

By month four, the insurer should complete a risk-tiered inventory and request missing information from vendors and business units. It should identify systems that influence pricing, eligibility, claims, fraud, reserves, investments, payments, or customer communications. Existing performance reports should be reviewed for data quality, drift, override behavior, complaints, and security events. A small number of unacceptable systems can be remediated first rather than waiting for a perfect enterprise program.

By month six, governance thresholds, validation standards, approval records, monitoring dashboards, and incident procedures should be operational. High-priority systems should undergo independent testing, while lower-risk tools should follow abbreviated reviews. Procurement templates should be amended to cover model changes, data use, subcontractors, exit assistance, and notification of security or control failures. Training should be role-specific: executives need oversight information, developers need release controls, underwriters need appropriate challenge procedures, and claims staff need escalation guidance.

By month 12, the first enterprise review should determine whether controls are working in practice. The insurer should examine the number of ungoverned systems, overdue validations, unresolved incidents, manual workarounds, vendor deficiencies, and projects that lacked risk approval. The board should receive a concise dashboard covering exposure, performance, exceptions, and investment needs. Controls should then be strengthened where evidence is weak. The timeline is illustrative rather than regulatory; a more complex carrier may need two or more years, while a smaller firm can sequence the work according to its most consequential systems.

## Common mistakes, pricing considerations, and when to act immediately

The most common mistake is treating AI governance as a technology project that ends after a tool launches. Governance is an operating discipline that continues through data changes, vendor releases, employee practices, and model retirement. A second error is assuming that an existing compliance review covers generative AI or autonomous agents; traditional vendor questionnaires may ask about encryption and uptime without testing hallucinations, model manipulation, access rights, or unsafe tool execution. A third mistake is collecting extensive documentation that no decision-maker uses.

Insurers also err by measuring accuracy alone. A model can have acceptable aggregate accuracy while failing badly for a particular class of customer, producing high review costs, or making a rare but catastrophic error. Equal metrics across historical data do not prove readiness for a changed environment. Another mistake is relying on historical claims data when the insured technology has little or no mature loss history. In that situation, the insurer should state its assumptions, use scenario ranges, compare expert and model judgments, and set limits that can be adjusted as evidence develops.

When pricing AI-related insurance, carriers should separate the cost of covering the underlying technology, cyber exposure, professional services, third-party dependencies, and consequential losses. Premiums depend on revenue, loss history, technology maturity, security maturity, contractual allocation, geographic exposure, and the reliability of controls; there is no defensible universal percentage. For a frontier AI company, a control that prevents one severe incident may be worth more than a modest premium saving, but expensive coverage is not necessarily broad coverage. Brokers should compare limits, deductibles, retroactive dates, exclusions, sublimits, definitions of insured AI, and claims-handling expertise.

Immediate action is warranted when an AI system already makes binding decisions, an insurer cannot identify who controls it, a vendor has withheld material information, or performance has materially deteriorated. Urgent review is also appropriate after a cyber event, model update, acquisition, regulatory inquiry, repeated customer complaint, or discovery that sensitive data was used without proper authorization. By contrast, there is usually no need to disrupt a low-impact drafting tool solely because it uses AI, provided privacy, security, and acceptable-use controls are proportionate. Effective insurer AI risk controls are therefore best understood as risk-based supervision: act quickly where exposure is high, simplify where consequences are limited, and never equate AI adoption with effective governance.

## What regulators, boards, and buyers should request as evidence

Boards and senior managers should receive evidence rather than promotional descriptions. Useful reporting includes the AI system inventory, risk tiers, accountable executives, approved uses, model-performance trends, independent validation findings, incidents, policy exceptions, vendor concentrations, and planned remediation. A claim that an insurer has an “AI framework” should be tested by examining recent decisions, such as whether a claims model was revalidated after a data-source change or whether an autonomous agent was actually restricted from executing payments above its authority.

Regulators are increasingly likely to expect demonstrable governance as regulatory activity expands. The exact obligations vary by jurisdiction, and insurers should not treat international articles as universal legal advice. Nevertheless, prudent documentation can include board oversight, management responsibilities, control testing, model inventories, validation reports, data governance, human review, and records of corrective action. S&P Global’s survey emphasis on governance, data readiness, and risk controls is relevant because it treats AI capability as an operating system rather than a collection of experimental projects.

Insurers buying insurance should request insurer-specific information where available: financial strength, regulatory status, appetite, underwriting methodology, security practices, privacy approach, vendor governance, complaints, and service for AI-related claims. A policy may respond differently to direct losses, network interruption, data restoration, third-party claims, regulatory investigation, or professional error. The market for AI-agent liability is developing, and forecast market-size figures should be treated cautiously because definitions and assumptions differ widely. The practical alternative is not simply “AI coverage versus no AI coverage,” but selecting among conventional cyber and liability policies, specialist products, contractual risk transfer, reserves, and specialist advice.

Ultimately, the best controls create an auditable chain from data to decision. Insurers should know what the system was intended to do, what it actually does, which version ran, who reviewed the result, what happened afterward, and whether performance remains acceptable. That chain is more valuable than a promise of perfect accuracy. It supports regulatory compliance, customer fairness, operational resilience, and better insurance purchasing while leaving room to adopt AI where the evidence supports doing so.

## Quick answers

### What is the first control an insurer should add for AI risk?

The first control is a complete inventory of internal and vendor-provided AI systems, paired with a named business owner for each consequential use. Management should then prioritize systems that affect pricing, eligibility, claims, fraud, reserves, payments, or customer communications. A broader governance program can follow the initial exposure assessment.

### Do small insurers need the same AI governance as large insurers?

Small insurers need the same accountability principles, but not the same staffing model or review depth. They may assign governance duties to existing executives and use external specialists for validation, privacy, cybersecurity, or actuarial review. Low-impact tools can receive abbreviated controls, while consequential models still require documented testing and monitoring.

### How should an insurer validate AI when claims data is limited?

It should combine available data with transparent assumptions, expert review, scenario analysis, and conservative underwriting limits. Historical comparisons can help, but they may not represent a frontier AI company or autonomous agent. The insurer should document uncertainty, test adverse scenarios, and revisit pricing or appetite as claims and near-miss evidence develop.

### What controls are especially important for autonomous AI agents?

Autonomous agents need least-privilege access, restricted tools, transaction limits, approval gates, detailed logs, anomaly detection, and a tested shutdown or rollback process. They should not be allowed to execute arbitrary code, change critical settings, or make unrestricted payments without an approved control. Human escalation should activate when confidence is low or the action exceeds defined authority.

### How much does insurer AI risk governance cost?

There is no universal price because cost depends on the number, type, and consequence of AI systems rather than the software license alone. A low-impact internal tool may need limited review, while production underwriting, claims, or agentic systems may require actuarial, legal, security, and independent validation work. The relevant calculation is the cost of proportionate assurance compared with the financial and operational exposure.

Canonical: https://in-surely.com/knowledge/how_should_insurers_build_ai_risk_controls_in_2026-2.php
Markdown: https://in-surely.com/knowledge/how_should_insurers_build_ai_risk_controls_in_2026-2.php/index.md